MBRX icon

Moleculin Biotech
MBRX

Overview Fund Trends Analyst Outlook Journalist POV

15 hedge funds and large institutions have $1.42M invested in Moleculin Biotech in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

9% less capital invested

Capital invested by funds: $1.56M → $1.42M (-$140K)

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$62.4K
2
+$49.7K
3
+$37K
4
VF
Virtu Financial
New York
+$26K
5
TSS
Two Sigma Securities
New York
+$21K

Top Sellers

1
-$29K
2
-$1.16K
3
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$855K
2
$167K
3
$159K
4
$47K
5
$37K
6
$29K
7
$26K
8
$25K
9
$23K
10
$21K
11
$15K
12
$7K
13
$5K
14
$4K
15
$1K
16
–
17
–